Opposing roles of activator protein-1 and CCAAT/enhancer binding protein β in the regulation of inducible granulysin gene expression in a human monocytic cell line, THP-1

Immunology

Volumn 107, Issue 4, 2002, Pages 507-516

  Kida, Yutaka ^a   Shimizu, Takashi ^a   Kuwano, Koichi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; GRANULYSIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OLIGONUCLEOTIDE; TOLL LIKE RECEPTOR 2; TRANSCRIPTION FACTOR AP 1; ANTIINFECTIVE AGENT; GNLY PROTEIN, HUMAN; T LYMPHOCYTE ANTIGEN;

ACHOLEPLASMA LAIDLAWII; ARTICLE; BINDING SITE; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; REGULATORY MECHANISM; REPORTER GENE; SIGNAL TRANSDUCTION; TRANSACTIVATION; ANIMAL; CELL LINE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; IMMUNOLOGY; METHODOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; RABBIT; WESTERN BLOTTING;

ACHOLEPLASMA LAIDLAWII; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BINDING SITES; BLOTTING, WESTERN; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL LINE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENE EXPRESSION REGULATION; HUMANS; MONOCYTES; PROMOTER REGIONS (GENETICS); RABBITS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC;

EID: 0036884082     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2002.01524.x     Document Type: Article

References (54)

1. Jongstra J, Schall TJ, Dyer BJ, Clayberger C, Jorgensen J, Davis MM, Krensky AM. The isolation and sequence of a novel gene from a human functional T cell line. J Exp Med 1987; 165:601-14.
2. Yabe T, McSherry C, Bach FH, Houchins JP. A cDNA clone expressed in natural killer and T cells that likely encodes a secreted protein. J Exp Med 1990; 172:1159-63.
3. Pena SV, Hanson DA, Carr BA, Goralski TJ, Krensky AM. Processing, subcellular localization, and function of 519 (granulysin), a human late T cell activation molecule with homology to small, lytic, granule proteins. J Immunol 1997; 158:2680-8.
4. Stenger S, Hanson DA, Teitelbaum R et al. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 1998; 282:121-5.
5. Wang Z, Choice E, Kaspar A, Hanson D, Okada S, Lyu SC, Krensky AM, Clayberger C. Bactericidal and tumoricidal activities of synthetic peptides derived from granulysin. J Immunol 2000; 165:1486-90.
6. Ernst WA, Thoma-Uszynski S, Teitelbaum R et al. Granulysin, a T cell product, kills bacteria by altering membrane permeability. J Immunol 2000; 165:7102-8.
7. Gamen S, Hanson DA, Kaspar A, Naval J, Krensky AM, Anel A. Granulysin-induced apoptosis. I. Involvement of at least two distinct pathways. J Immunol 1998; 161:1758-64.
8. Kaspar AA, Okada S, Kumar J et al. A distinct pathway of cell-mediated apoptosis initiated by granulysin. J Immunol 2001; 167:350-6.
9. Pardo J, Perez-Galan P, Gamen S et al. A role of the mitochondrial apoptosis-inducing factor in granulysin-induced apoptosis. J Immunol 2001; 167:1222-9.
10. Mori S, Jewett A, Cavalcanti M, Murakami-Mori K, Nakamura S, Bonavida B. Differential regulation of human NK cell-associated gene expression following activation by IL-2, IFN-α and PMA/ionomycin. Int J Oncol 1998; 12:1165-70.
11. Tsutsumi-Ishii Y, Hasebe T, Nagaoka I. Role of CCAAT/enhancer-binding protein site in transcription of human neutrophil peptide-1 and -3 defensin genes. J Immunol 2000; 164:3264-73.
12. Krisanaprakornkit S, Kimball JR, Dale BA. Regulation of human β-defensin-2 in gingival epithelial cells: the involvement of mitogen-activated protein kinase pathways, but not the NF-kB transcription factor family. J Immunol 2002; 168:316-24.
13. Tsutsumi-Ishii Y. Nagaoka I. NF-kB-mediated transcriptional regulation of human β-defensin-2 gene following lipopolysaccharide stimulation. J Leukoc Biol 2002; 71:154-62.
14. Kida Y, Kuwano K, Zhang Y, Arai S. Acholeplasma laidlawii up-regulates granulysin gene expression via transcription factor activator protein-1 in a human monocytic cell line, THP-1. Immunology 2001; 104:324-32.
15. Flo TH, Halaas O, Lien E, Ryan L, Teti G, Golenbock DT, Sundan A, Espevik T. Human toll-like receptor 2 mediates monocyte activation by Listeria monocytogenes, but not by group B streptococci or lipopolysaccharide. J Immunol 2000; 164:2064-9.
16. Kuwano K, Ono S, Akashi A, Ohishi M, Shigematsu H, Arai S. Production of a T-cell clone which reacts with membrane proteins of Acholeplasma laidlawii. Microbiol Immunol 1997; 41:261-4.
17. Manning WC, O'Farrell S, Goralski TJ, Krensky AM. Genomic structure and alternative splicing of 519, a gene expressed late after T cell activation. J Immnnol 1992; 148:4036-42.
18. Houchins JP, Kricek F, Chujor CS, Heise CP, Yabe T, McSherry C, Bach FH. Genomic structure of NKG5, a human NK and T cell-specific activation gene. Immunogenetics 1993; 37:102-7.
19. Imai Y, Matsushima Y, Sugimura T, Terada M. A simple and rapid method for generating a deletion by PCR. Nucl Acids Res 1991; 19:2785.
20. Gough NM. Rapid and quantitative preparation of cytoplasmic RNA from small numbers of cells. Anal Biochem 1988; 173:93-5.
21. Descombes P, Schibler U. A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 1991; 67:569-79.
22. Honda Y, Rogers L, Nakata K et al. Type I interferon induces inhibitory 16-kD CCAAT/enhancer binding protein (C/EBP) β, repressing the HIV-1 long terminal repeat in macrophages: pulmonary tuberculosis alters C/EBP expression, enhancing HIV-1 replication. J Exp Med 1998; 188:1255-65.
23. Baseman JB, Tully JG. Mycoplasmas: sophisticated, reemerging, and burdened by their notoriety. Emerg Infect Dis 1997; 3:21-32.
24. Feng SH, Lo SC. Induced mouse spleen B-cell proliferation and secretion of immunoglobulin by lipid-associated membrane proteins of Mycoplasma fermentans incognitus and Mycoplasma penetrans. Infect Immun 1994; 62:3916-21.
25. Herbelin A, Ruuth E, Delorme D, Michel-Herbelin C, Praz F. Mycoplasma arginini TUH-14 membrane lipoproteins induce production of interleukin-1, interleukin-6, and tumor necrosis factor alpha by human monocytes. Infect Immun 1994; 62:4690-4.
26. Kostyal DA, Butler GH, Beezhold DH. A 48-kilodalton Mycoplasma fermentans membrane protein induces cytokine secretion by human monocytes. Infect Immun 1994; 62:3793-800.
27. Muhlradt PF, Kiess M, Meyer H, Sussmuth R, Jung G. Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration. J Exp Med 1997; 185:1951-8.
28. Muhlradt PF, Kiess M, Meyer H, Sussmuth R, Jung G. Structure and specific activity of macrophage-stimulating lipopeptides from Mycoplasma hyorhinis. Infect Immun 1998; 66:4804-10.
29. Takeuchi O, Kaufmann A, Grote K, Kawai T, Hoshino K, Morr M, Muhlradt PF, Akira S. Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway. J Immunol 2000; 164:554-7.
30. Nishiguchi M, Matsumoto M, Takao T et al. Mycoplasma fermentans lipoprotein M161Ag-induced cell activation is mediated by Toll-like receptor 2: role of N-terminal hydrophobic portion in its multiple functions. J Immunol 2001; 166:2610-16.
31. Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-κB. Annu Rev Cell Biol 1994; 10:405-55.
32. Thanos D, Maniatis T. NF-κB: a lesson in family values. Cell 1995; 80:529-32.
33. Baeuerle PA, Baltimore D. NF-κB: ten years after. Cell 1996; 87:13-20.
34. Kunsch C, Ruben SM, Rosen CA. Selection of optimal κB/Rel DNA-binding motifs: interaction of both subunits of NF-κB with DNA is required for transcriptional activation. Mol Cell Biol 1992; 12:4412-21.
35. Urban MB, Baeuerle PA. The 65-kD subunit of NF-κB is a receptor for IκB and a modulator of DNA-binding specificity. Genes Dev 1990; 4:1975-84.
36. Akira S, Isshiki H, Sugita T et al. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J 1990; 9:1897-906.
37. Natsuka S, Akira S, Nishio Y, Hashimoto S, Sugita T, Isshiki H, Kishimoto T. Macrophage differentiation-specific expression of NF-IL6, a transcription factor for interleukin-6. Blood 1992; 79:460-6.
38. Pope RM, Leutz A, Ness SA. C/EBPβ regulation of the tumor necrosis factor α gene. J Clin Invest 1994; 94:1449-55.
39. Medzhitov R, Janeway CA, Innate immunity: the virtues of a nonclonal system of recognition. Cell 1997; 91:295-8.
40. Hoffmann JA, Kafatos FC, Janeway CA, Ezekowitz RA. Phylogenetic perspectives in innate immunity. Science 1999; 284:1313-18.
41. Medzhitov R, Preston-Hurlburt P, Janeway CA. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997; 388:394-7.
42. Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF. A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci USA 1998; 95:588-93.
43. Takeuchi O, Kawai T, Sanjo H, Copeland NG, Gilbert DJ, Jenkins NA, Takeda K, Akira S. TLR6: a novel member of an expanding toll-like receptor family. Gene 1999; 231:59-65.
44. Chuang TH, Ulevitch RJ. Cloning and characterization of a subfamily of human toll-like receptors: hTLR7, hTLR8 and hTLR9. Eur Cytokine Netw 2000; 11:372-8.
45. Hemmi HH, Takeuchi O, Kawai T et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408:740-5.
46. Chuang T, Ulevitch RJ. Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells. Biochim Biophys Acta 2001; 1518:157-61.
47. Hirschfeld M, Kirschning CJ, Schwandner R, Wesche H, Weis JH, Wooten RM, Weis JJ. Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2. J Immunol 1999; 163:2382-6.
48. Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 1999; 274:17406-9.
49. Poltorak A, He X, Smirnova I et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282:2085-8.
50. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature 2000; 406:782-7.
51. Feng SH, Lo SC. Lipid extract of Mycoplasma penetrans proteinase K-digested lipid-associated membrane proteins rapidly activates NF-κB and activator protein 1. Infect Immun 1999; 67:2951-6.
52. Sugama K, Kuwano K, Furukawa M, Himeno Y, Satoh T, Arai S. Mycoplasmas induce transcription and production of tumor necrosis factor in a monocytic cell line, THP-1, by a protein kinase C-independent pathway. Infect Immun 1990; 58:3564-7.
53. Takeuchi O, Kawai T, Muhlradt PF, Morr M, Radolf JD, Zychlinsky A, Takeda K, Akira S. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int Immunol 2001; 13:933-40.
54. Thoma-Uszynski S, Stenger S, Takeuchi O et al. Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 2001; 291:1544-7.